Johnson & Johnson vs Nokia Corp — how do they compare? Johnson & Johnson trades at $250.66 (market cap $598.96B), while Nokia Corp trades at $10.93 (market cap $56.70B). The key difference: Johnson & Johnson is far larger — about 10.6× Nokia Corp's market cap, and Johnson & Johnson pays the higher dividend (2.15%). Which is the better fit depends on your goals.
| JNJ | NOK | |
|---|---|---|
Market Cap | $598.96B | $56.70B |
Volume | 6,156,228 | — |
Sector | Health | Technology |
52-Week High | $267.24 | $16.83 |
52-Week Low | $164.36 | $4.05 |
Enterprise Value | $631.90B | $53.51B |
Dividend Yield | 2.15% | 1.63% |
Trailing returns across standard periods
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →Nokia is a leading vendor in the telecommunications equipment industry. The company's network business derives revenue from selling wireless and fixed-line hardware, software, and services. Nokia's technology segment licenses its patent portfolio to handset manufacturers and makes royalties from Nokia-branded cellphones. The company, headquartered in Espoo, Finland, operates on a global scale, with most of its revenue from communication service providers.
Read more on NOK →